公开(公告)号：US09433596B2

公开(公告)日：2016-09-06

申请号：US13820954

申请日：2010-09-06

申请人： Suk Woo Choi ,  Suk Won Lee ,  Jeong Yeon Kim ,  Beom Jong Song ,  In Gie Hong ,  Sung Mo Park ,  Ji Hye Kim ,  Jun Uk Lee ,  Bo Bae An

发明人： Suk Woo Choi ,  Suk Won Lee ,  Jeong Yeon Kim ,  Beom Jong Song ,  In Gie Hong ,  Sung Mo Park ,  Ji Hye Kim ,  Jun Uk Lee ,  Bo Bae An

IPC分类号： A61K31/198 ,  A61K31/195 ,  A61K31/355 ,  A61K31/51 ,  A61K31/525 ,  A61K45/06 ,  A61K38/05 ,  A61K38/17 ,  A61K38/18 ,  A61K38/21 ,  A61K31/18 ,  A61K31/216 ,  A61K31/55 ,  A61K31/5513 ,  A61K31/702

CPC分类号： A61K31/198 ,  A61K31/18 ,  A61K31/195 ,  A61K31/216 ,  A61K31/355 ,  A61K31/51 ,  A61K31/525 ,  A61K31/55 ,  A61K31/5513 ,  A61K31/702 ,  A61K38/05 ,  A61K38/1709 ,  A61K38/1825 ,  A61K38/1833 ,  A61K38/1866 ,  A61K38/21 ,  A61K45/06 ,  A61K2300/00

摘要： The present disclosure relates to a composition for treating anxiety disorder, particularly to a pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder such as post traumatic stress disorder or phobia. In accordance with the present disclosure, N-acetyl-L-cysteine can block the renewal of fear memories for a sustained period of time when it was administered during or after an exposure therapy to treat post traumatic stress disorder or phobia.

摘要翻译： 本公开涉及用于治疗焦虑症的组合物，特别是涉及包含N-乙酰基-L-半胱氨酸或其衍生物用于治疗焦虑症例如创伤后应激障碍或恐惧症的药物组合物。 根据本公开，N-乙酰基-L-半胱氨酸可以在暴露治疗期间或之后施用持续的持续时间段来阻止恐惧记忆的更新以治疗创伤后应激障碍或恐惧症。

公开(公告)号：US20130172418A1

公开(公告)日：2013-07-04

申请号：US13820954

申请日：2010-09-06

申请人： Suk Woo Choi ,  Suk Won Lee ,  Jeong Yeon Kim ,  Beom Jong Song ,  In Gie Hong ,  Sung Mo Park ,  Ji Hye Kim ,  Jun Uk Lee ,  Bo Bae An

发明人： Suk Woo Choi ,  Suk Won Lee ,  Jeong Yeon Kim ,  Beom Jong Song ,  In Gie Hong ,  Sung Mo Park ,  Ji Hye Kim ,  Jun Uk Lee ,  Bo Bae An

IPC分类号： A61K31/198 ,  A61K45/06

CPC分类号： A61K31/198 ,  A61K31/18 ,  A61K31/195 ,  A61K31/216 ,  A61K31/355 ,  A61K31/51 ,  A61K31/525 ,  A61K31/55 ,  A61K31/5513 ,  A61K31/702 ,  A61K38/05 ,  A61K38/1709 ,  A61K38/1825 ,  A61K38/1833 ,  A61K38/1866 ,  A61K38/21 ,  A61K45/06 ,  A61K2300/00

摘要： The present disclosure relates to a composition for treating anxiety disorder, particularly to a pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder such as post traumatic stress disorder or phobia. In accordance with the present disclosure, N-acetyl-L-cysteine can block the renewal of fear memories for a sustained period of time when it was administered during or after an exposure therapy to treat post traumatic stress disorder or phobia.

摘要翻译： 本公开涉及用于治疗焦虑症的组合物，特别是涉及包含N-乙酰基-L-半胱氨酸或其衍生物用于治疗焦虑症例如创伤后应激障碍或恐惧症的药物组合物。 根据本公开，N-乙酰基-L-半胱氨酸可以在暴露治疗期间或之后施用持续的持续时间段来阻止恐惧记忆的更新以治疗创伤后应激障碍或恐惧症。